ID
45757
Description
Principal Investigator: Daphne W. Bell, PhD, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA MeSH: Endometrial Neoplasms,Carcinosarcoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001152 The purpose of this study was to identify somatic (tumor-specific) mutations in endometrial carcinosarcoma tumor exomes. The dataset was generated at the NIH Intramural Sequencing Center (NISC) and NHGRI by next generation sequencing the exomes of 14 de-identified primary tumor DNAs and matched non-tumor DNAs.
Lien
Mots-clés
Versions (1)
- 14/06/2023 14/06/2023 - Chiara Middel
Détendeur de droits
Daphne W. Bell, PhD, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
Téléchargé le
14 juin 2023
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs001152 Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas
Subject ID, consent group, and affection status of participants with endometrial carcinosarcomas tumors and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with endometrial carcinosarcomas tumors and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Subject ID and sex of participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor or metastasis, primary tumor location, and name of the center which conducted sequencing of samples obtained from participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
Similar models
Subject ID, consent group, and affection status of participants with endometrial carcinosarcomas tumors and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with endometrial carcinosarcomas tumors and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Subject ID and sex of participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor or metastasis, primary tumor location, and name of the center which conducted sequencing of samples obtained from participants with endometrial carcinosarcomas and involved in the "Somatic Mutational Analysis by Exome Sequencing Endometrial Carcinosarcomas" project.
C0441833 (UMLS CUI [1,2])
Aucun commentaire